Humulin M3 KwikPen (mixture 3) 100 IU/ml Suspension for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

humulin m3 kwikpen (mixture 3) 100 iu/ml suspension for injection

eli lilly nederland b.v. - human insulin (recombinant dna origin) - suspension for injection - 100 international unit(s)/millilitre - insulins and analogues for injection, intermediate- or long-acting combined with fast-acting; insulin (human)

Humulin I (Isophane) 100 IU/ml Suspension for Injection in vial Ireland - English - HPRA (Health Products Regulatory Authority)

humulin i (isophane) 100 iu/ml suspension for injection in vial

eli lilly nederland b.v. - human insulin (recombinant dna origin) - suspension for injection - 100 international unit(s)/millilitre - insulins and analogues for injection, intermediate-acting; insulin (human)

Humulin M3 (Mixture 3) 100 IU/ml Suspension for Injection in vial Ireland - English - HPRA (Health Products Regulatory Authority)

humulin m3 (mixture 3) 100 iu/ml suspension for injection in vial

eli lilly nederland b.v. - human insulin (recombinant dna origin) - suspension for injection - 100 international unit(s)/millilitre - insulins and analogues for injection, intermediate- or long-acting combined with fast-acting; insulin (human)

Humulin S (Soluble) 100 IU/ml Solution for Injection in vial Ireland - English - HPRA (Health Products Regulatory Authority)

humulin s (soluble) 100 iu/ml solution for injection in vial

eli lilly nederland b.v. - human insulin (recombinant dna origin) - solution for injection in vial - 100 international unit(s)/millilitre - insulins and analogues for injection, fast-acting; insulin (human)

Humulin I (Isophane) 100IU/ml Suspension for Injection in cartridge Malta - English - Malta Medicines Authority

humulin i (isophane) 100iu/ml suspension for injection in cartridge

eli lilly nederland b.v papendorpseweg 83, 3528 bj, utrecht, nl-3991, netherlands - insulin human, rdna - suspension for injection - insulin human (rdna) 100 iu - drugs used in diabetes

Humatrope Pdr+Solv for Soln for Inj 6mg Malta - English - Malta Medicines Authority

humatrope pdr+solv for soln for inj 6mg

eli lilly nederland b.v papendorpseweg 83, 3528 bj, utrecht, nl-3991, netherlands - somatropin - powder and solvent for solution for injection - somatropin 6 mg - pituitary and hypothalamic hormones and analogues

Humatrope Pdr+Solv for Soln for Inj 24mg Malta - English - Malta Medicines Authority

humatrope pdr+solv for soln for inj 24mg

eli lilly nederland b.v papendorpseweg 83, 3528 bj, utrecht, nl-3991, netherlands - somatropin - powder and solvent for solution for injection - somatropin 24 mg - pituitary and hypothalamic hormones and analogues

Humatrope Pdr+Solv for Soln for Inj 12mg Malta - English - Malta Medicines Authority

humatrope pdr+solv for soln for inj 12mg

eli lilly nederland b.v papendorpseweg 83, 3528 bj, utrecht, nl-3991, netherlands - somatropin - powder and solvent for solution for injection - somatropin 12 mg - pituitary and hypothalamic hormones and analogues

Alimta European Union - English - EMA (European Medicines Agency)

alimta

eli lilly nederland b.v. - pemetrexed - mesothelioma; carcinoma, non-small-cell lung - antineoplastic agents - malignant pleural mesotheliomaalimta in combination with cisplatin is indicated for the treatment of chemotherapy-naïve patients with unresectable malignant pleural mesothelioma.non-small-cell lung canceralimta in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous cell histology.alimta is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy.alimta is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous cell histology.

Rayvow European Union - English - EMA (European Medicines Agency)

rayvow

eli lilly nederland b.v. - lasmiditan succinate - migraine disorders - analgesics - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.